Evidence map›Paper›PMID 21490622›Full record

Trial reportJournal of human hypertension2012

Regional grey matter shrinks in hypertensive individuals despite successful lowering of blood pressure.

J R Jennings, D N Mendelson, M F Muldoon, C M Ryan, P J Gianaros, N Raz, H Aizenstein

Abstract readComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in Journal of human hypertension, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Characteristic changes in the default mode network in hypertensive patients with cognitive impairment.Hypertension research : official journal of the Japanese Society of Hypertension · 2019
    Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

J R JenningsDepartment of Psychiatry and Psychology, University of Pittsburgh, Pittsburgh, PA 15213, USA. JenningsJR@upmc.edu
D N Mendelson
M F Muldoon
C M Ryan
P J Gianaros
N Raz
H Aizenstein

Funding

Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
RECRUITMENT COREU19AG010483 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FELDMAN, HOWARD · 2013 to 2020
$80.6M
Neural Correlates and Modifiers of Cognitive AgingR37AG011230 · NIA · WAYNE STATE UNIVERSITY · PI RAZ, NAFTALI · 2005 to 2014
$5.2M
NEURAL CORRELATES OF AGE-RELATED DIFFERENCES IN MEMORYR01AG011230 · NIA · WAYNE STATE UNIVERSITY · PI DAUGHERTY, ANA MARIE, RAZ, NAFTALI · 1993 to 2020
$4.8M
COGNITIVE AND CEREBROVASCULAR SEQUELAE OF HYPERTENSIONR01HL057529 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JENNINGS, JOHN RICHARD · 1997 to 2004
$2.7M
The Brain as a Target for Pre and Essential HypertensionR01HL101959 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JENNINGS, JOHN RICHARD · 2010 to 2014
$2.1M
Functional Organization of Cardiovascular ReactivityK01MH070616 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GIANAROS, PETER J · 2004 to 2008
$593k
NHLBI NIH HHS HL57529NHLBI NIH HHS R01 HL057529NHLBI NIH HHS R01 HL101959NIA NIH HHS AG011230NIA NIH HHS R37 AG011230NIA NIH HHS U01 AG024904NIA NIH HHS U19 AG010483NIMH NIH HHS MH-K01-070616PHS HHS HLR01-089850
6 · The paper itself

Abstract

The aim of the study was to determine whether the reduction in brain grey matter volume associated with hypertension persisted or was remediated among hypertensive patients newly treated over the course of a year. A total of 41 hypertensive patients were assessed over the course of a 1-year successful anti-hypertensive treatment. Brain areas identified previously in cross-sectional studies differing in volume between hypertensive and normotensive individuals were examined with a semi-automated measurement technique (automated labelling pathway). Volumes of grey matter regions were computed at baseline after a year of treatment and compared with archival data from normotensive individuals. Reductions in regional grey matter volume over the follow-up period were observed despite successful treatment of blood pressure (BP). The comparison group of older, but normotensive, individuals showed no significant changes over a year in the regions tested in the treated hypertensive group. These novel results suggest that essential hypertension is associated with regional grey matter shrinkage, and successful reduction of BP may not completely counter that trend.

Indexed as

Adrenergic beta-AntagonistsAdultAgedAngiotensin-Converting Enzyme InhibitorsAntihypertensive AgentsAtrophyBlood PressureBrainBrain DiseasesDouble-Blind MethodFemaleHumansHypertensionLinear ModelsLongitudinal StudiesMagnetic Resonance ImagingAdrenergic beta-AntagonistsAngiotensin-Converting Enzyme InhibitorsAntihypertensive Agents

Identifiers

PMID21490622
PMCPMC3137674

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.